CDK5 Inhibition Abrogates TNBC Stem‐Cell Property and Enhances Anti‐PD‐1 Therapy-Reference-Cited by-同舟云学术

CDK5 Inhibition Abrogates TNBC Stem‐Cell Property and Enhances Anti‐PD‐1 Therapy

Published:2020-10-15 Issue:22 Volume:7 Page:2001417
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Adv. Sci.

Author:

Bei Yuncheng¹,Cheng Nan¹,Chen Ting¹²,Shu Yuxin¹,Yang Ye³,Yang Nanfei¹,Zhou Xinyu⁴,Liu Baorui⁵,Wei Jia⁵,Liu Qin⁵,Zheng Wei¹,Zhang Wenlong¹,Su Huifang¹,Zhu Wei‐Guo⁶,Ji Jianguo⁴,Shen Pingping¹⁶^ORCID

Affiliation:

1. State Key Laboratory of Pharmaceutical Biotechnology and The Comprehensive Cancer Center Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School Nanjing University Nanjing 210046 P. R. China

2. Laura and Isaac Perlmutter Cancer Center New York University Langone Medical Center New York NY USA

3. State Key Laboratory Cultivation Base for TCM Quality and Efficacy Nanjing University of Chinese Medicine Nanjing 210023 P. R. China

4. State Key Laboratory of Protein and Plant Gene Research College of Life Sciences Peking University Beijing 100871 P. R. China

5. The Comprehensive Cancer Center Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School Nanjing 210008 P. R. China

6. Guangdong Key Laboratory of Genome Instability and Human Disease Shenzhen University Carson Cancer Center Department of Biochemistry and Molecular Biology Shenzhen University School of Medicine Shenzhen 518060 P. R. China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202001417

Reference61 articles.

1. Breast cancer metastasis: markers and models

2. Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer

3. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

4. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

5. New Opportunities and Challenges to Defeat Cancer Stem Cells

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD-L1 expression and tumor-infiltrating lymphocytes: Correlations and prognostic values in Chinese triple-negative breast cancer patients with different molecular subtyping;Pathology - Research and Practice;2024-10

2. CD44 and its implication in neoplastic diseases;MedComm;2024-05-23

3. Binding kinetics of ten small-molecule drug candidates on SARS-CoV-2 3CLpro revealed by biomolecular simulations;Medicine in Novel Technology and Devices;2023-12

4. CDK5: an oncogene or an anti-oncogene: location location location;Molecular Cancer;2023-11-23

5. CDK5 promotes apoptosis and attenuates chemoresistance in gastric cancer via E2F1 signaling;Cancer Cell International;2023-11-21